Japan · Delayed Price · Currency is JPY Kohjin Bio Statistics
Total Valuation
Kohjin Bio has a market cap or net worth of JPY 4.33 billion. The enterprise value is 3.79 billion.
| Market Cap | 4.33B |
| Enterprise Value | 3.79B |
Important Dates
The last earnings date was Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Kohjin Bio has 5.11 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 5.11M |
| Shares Outstanding | 5.11M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 55.34% |
| Owned by Institutions (%) | 15.65% |
| Float | 1.54M |
Valuation Ratios
The trailing PE ratio is 33.82.
| PE Ratio | 33.82 |
| Forward PE | n/a |
| PS Ratio | 0.92 |
| PB Ratio | 0.74 |
| P/TBV Ratio | 0.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 6.20 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 29.57 |
| EV / Sales | 0.81 |
| EV / EBITDA | 6.22 |
| EV / EBIT | 18.56 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.31.
| Current Ratio | 1.77 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 3.27 |
| Debt / FCF | -6.75 |
| Interest Coverage | 4.03 |
Financial Efficiency
Return on equity (ROE) is 2.21% and return on invested capital (ROIC) is 2.03%.
| Return on Equity (ROE) | 2.21% |
| Return on Assets (ROA) | 1.09% |
| Return on Invested Capital (ROIC) | 2.03% |
| Return on Capital Employed (ROCE) | 2.44% |
| Weighted Average Cost of Capital (WACC) | 3.45% |
| Revenue Per Employee | 26.67M |
| Profits Per Employee | 727,273 |
| Employee Count | 176 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 3.40 |
Taxes
In the past 12 months, Kohjin Bio has paid 52.00 million in taxes.
| Income Tax | 52.00M |
| Effective Tax Rate | 28.89% |
Stock Price Statistics
The stock price has decreased by -50.52% in the last 52 weeks. The beta is 0.00, so Kohjin Bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.00 |
| 52-Week Price Change | -50.52% |
| 50-Day Moving Average | 894.86 |
| 200-Day Moving Average | 1,227.07 |
| Relative Strength Index (RSI) | 39.90 |
| Average Volume (20 Days) | 1,935 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kohjin Bio had revenue of JPY 4.69 billion and earned 128.00 million in profits. Earnings per share was 25.04.
| Revenue | 4.69B |
| Gross Profit | 1.67B |
| Operating Income | 157.00M |
| Pretax Income | 180.00M |
| Net Income | 128.00M |
| EBITDA | 562.00M |
| EBIT | 157.00M |
| Earnings Per Share (EPS) | 25.04 |
Balance Sheet
The company has 2.38 billion in cash and 1.84 billion in debt, with a net cash position of 544.00 million or 106.42 per share.
| Cash & Cash Equivalents | 2.38B |
| Total Debt | 1.84B |
| Net Cash | 544.00M |
| Net Cash Per Share | 106.42 |
| Equity (Book Value) | 5.88B |
| Book Value Per Share | 1,150.52 |
| Working Capital | 1.83B |
Cash Flow
In the last 12 months, operating cash flow was 698.00 million and capital expenditures -970.00 million, giving a free cash flow of -272.00 million.
| Operating Cash Flow | 698.00M |
| Capital Expenditures | -970.00M |
| Depreciation & Amortization | 405.00M |
| Net Borrowing | -150.00M |
| Free Cash Flow | -272.00M |
| FCF Per Share | -53.21 |
Margins
Gross margin is 35.66%, with operating and profit margins of 3.34% and 2.73%.
| Gross Margin | 35.66% |
| Operating Margin | 3.34% |
| Pretax Margin | 3.83% |
| Profit Margin | 2.73% |
| EBITDA Margin | 11.97% |
| EBIT Margin | 3.34% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 10.00, which amounts to a dividend yield of 1.17%.
| Dividend Per Share | 10.00 |
| Dividend Yield | 1.17% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | 1.17% |
| Earnings Yield | 2.96% |
| FCF Yield | -6.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Kohjin Bio has an Altman Z-Score of 2.87 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.87 |
| Piotroski F-Score | 5 |